The RYTHM, Inc. (RYM) SEC filings page on Stock Titan is designed to help investors and researchers review the company’s regulatory disclosures in a structured way. RYTHM, formerly known as Agrify Corporation, is a Nasdaq-listed issuer that reports on its hemp-derived THC brand portfolio, financial performance and risk factors through filings with the U.S. Securities and Exchange Commission.
Through this page, users can access core filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q, where RYTHM discusses revenue from continuing operations, operating losses, cash balances, goodwill and intangible assets, debt obligations and equity. These reports also contain management’s discussion of business strategy, including ownership of brand intellectual property and licensing arrangements for manufacturing and distribution of THC products.
When available, current reports on Form 8-K provide details on material events, such as the company’s name change to RYTHM, Inc., the adoption of the RYM ticker, or acquisitions of brand intellectual property. Proxy statements and related documents can offer additional insight into governance and other corporate matters.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand important changes in RYTHM’s business, capital structure and risk disclosures. Real-time updates from EDGAR ensure that new filings appear promptly, while dedicated sections for ownership reports, such as Form 4 when available, make it easier to monitor insider transactions and changes in beneficial ownership.
Together, these tools give a clearer view of how RYTHM presents its hemp-derived THC brand strategy, financial condition and risk profile in its official SEC reporting.
Shapiro Peter S. reported acquisition or exercise transactions in this Form 4 filing.
RYTHM, Inc. director Peter S. Shapiro received a grant of 5,000 shares of common stock in the form of restricted stock units under the company’s 2022 Omnibus Equity Incentive Plan. All units vest in a single tranche on the earlier of one year from grant or the next annual stockholder meeting, subject to his continuous service, bringing his direct holdings to 11,300 shares.
MAHONEY TIMOTHY reported acquisition or exercise transactions in this Form 4 filing.
RYTHM, Inc. director Timothy Mahoney received an equity award of 5,000 shares of Common Stock in the form of restricted stock units. The units were granted at no cash cost and are part of the company’s 2022 Omnibus Equity Incentive Plan.
All 5,000 restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders, provided Mahoney continues to serve the company through that vesting date. After this award, he holds 5,000 shares directly.
Varier Krishnan reported acquisition or exercise transactions in this Form 4 filing.
RYTHM, Inc. director Varier Krishnan received an equity award of 5,000 shares of Common Stock via restricted stock units. The grant was made at a price of $0.00 per share as compensation, not an open-market purchase. After this award, Krishnan directly holds 10,000 shares of the company.
According to the terms, 100% of the restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders, as long as Krishnan continues to serve the company through that vesting date.
RYTHM, Inc. director Armon Vakili reported both a stock award and share sales. On June 16, Vakili received 5,000 restricted stock units under the company’s 2022 Omnibus Equity Incentive Plan, vesting in full on the earlier of one year from grant or the next annual stockholder meeting, subject to continued service.
On June 17, Vakili sold a total of 2,250 shares of common stock in open-market transactions at weighted average prices generally ranging from about $25.00 to $27.41 per share. After these transactions, Vakili directly holds 10,850 shares of RYTHM common stock.
RYTHM, Inc. reported results of its 2026 annual stockholder meeting, where stockholders approved an amendment to the 2022 Omnibus Equity Incentive Plan to increase the shares available for equity awards by 115,000. All seven director nominees were elected for one-year terms continuing until the 2027 meeting or until successors are elected and qualified. Stockholders also ratified the appointment of GuzmanGray as independent registered public accounting firm for the year ending December 31, 2026. At the meeting, 1,560,696 shares out of 2,149,128 issued and outstanding as of April 20, 2026 were represented, representing approximately 72.61% of eligible shares and constituting a quorum.
RYTHM, Inc. director Timothy Mahoney reported a series of open-market sales of the company’s Common Stock. On June 11, he sold a total of 5,000 shares in five separate transactions at prices ranging from about $24.88 to $28.00 per share. All transactions involved direct ownership, and no option exercises or other derivative transactions were reported in this filing.
RYTHM, Inc. reported a sharp turnaround in the quarter ended March 31, 2026 as it executed its shift from cannabis equipment to hemp-derived THC brands and licensing. Revenue from continuing operations rose to $13.3 million from $0.5 million a year earlier, driven mainly by $10.0 million of licensing revenue and $3.3 million of product sales.
The company posted net income of $19.9 million versus a prior-year loss, largely due to a $25.6 million income tax benefit from releasing a valuation allowance after amending its Green Thumb license to a fixed-fee structure. That amendment entitles RYTHM to $70 million per year of fixed license payments, recognized ratably over the term.
Cash and cash equivalents were $33.3 million, and operating activities generated $1.0 million of cash. Total assets reached $127.5 million and stockholders’ equity increased to $36.6 million. The balance sheet also shows $80.6 million of debt, including $72.0 million of related-party convertible notes classified as current, and the business is highly concentrated in a related-party customer that represented 75% of Q1 revenue.
RYTHM, Inc. reported strong top-line growth for the first quarter of 2026, with revenue rising to $13,286 thousand from $538 thousand a year earlier. Gross profit reached $10,397 thousand on significantly higher sales.
The company posted net income from continuing operations of $19,922 thousand, driven largely by an income tax benefit of $25,593 thousand. On an operating basis, RYTHM recorded an EBITDA loss of $486 thousand and Adjusted EBITDA of $(21) thousand, nearly breakeven.
RYTHM ended March 31, 2026 with $33,261 thousand in cash and cash equivalents and generated $1,043 thousand of cash from operating activities in the quarter. Management highlighted 24% sequential revenue growth, a 78% gross margin, and brand leadership across key THC categories, while noting regulatory uncertainty around a potential federal hemp ban.